JCHOR
Journal of Current Hematology & Oncology Research

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge.

ISSN: Active
eISSN: 2980-0854
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Evaluation of the response and adverse effects of intravenous iron therapy in patients with iron deficiency anemia: a single-center experience
Abstract
Aims: The present study evaluates the treatment responses and adverse effect profile of intravenous (IV) iron (ferric carboxymaltose) therapy in patients diagnosed with iron deficiency anemia (IDA).
Methods: The medical records of 65 patients diagnosed with IDA and treated with IV iron therapy after presenting to various clinics in our center between 2014 and 2023 were retrospectively reviewed. Pre- and post-treatment hemoglobin (Hb), serum iron, total iron-binding capacity (TIBC), ferritin, and transferrin saturation levels were compared, treatment-related adverse effects were recorded, and improvements in symptoms were noted.
Results: The patients were aged 18–90 years, and 89.2% (n=58) were female. Significant improvements were observed in all laboratory parameters following IV iron therapy. The mean Hb increased from 9.8 g/dL before treatment to 12.7 g/dL after treatment (p<0.001); while the median serum ferritin increased from 4.6 µg/L before treatment to 231 µg/L after treatment, indicating a replenishment of iron stores (p<0.001). All patients experienced an improvement in clinical symptoms, while six (9.2%) developed an allergic reaction to the IV iron therapy.
Conclusion: The present study demonstrated that IV iron therapy rapidly and significantly increases Hb levels and replenishes iron stores, alleviates symptoms, and exhibits an acceptable safety profile in patients with IDA. The incidence of serious adverse effects from IV iron therapy is low, and it can thus be considered an effective treatment approach, particularly in patients who are unresponsive to or intolerant of oral iron therapy.

Keywords : Anemia, ferric carboxymaltose, ferritins, iron-deficiency, intravenous

Download Article


1. Kassebaum NJ, Jasrasaria R, Naghavi M, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014;123(5):615-624. doi:10.1182/blood-2013-06-508325
2. U¨nal S, Balcı YI·, Toprak SK. Eritrosit hastalıkları ve hemoglobin bozuklukları tanı ve tedavi kılavuzu. Bo¨lu¨m III: Yetis¸kinde Demir Eksikligˆi Tanı ve Tedavi Kılavuzu. Ankara: Tu¨rk Hematoloji Dernegˆi; 2011:23-33.
3. Allen RP, Auerbach S, Bahrain H, et al. The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia. Am J Hematol. 2013;88(4):261-264. doi:10.1002/ajh.23391
4. Sharma R, Stanek JR, Koch TL, et al. Intravenous iron therapy in nonanemic iron- deficient menstruating adolescent females with fatigue. Am J Hematol. 2016;91(10):973-977. doi:10.1002/ajh.24441
5. Kruske SG, Ruben AR, Brewster DR. An iron treatment trial in an Aboriginal community: improving non- adherence. J Paediatr Child Health. 1999;35(2):153-158. doi:10.1046/j.1440-1754.1999.00331.x
6. Werner E, Kaltwasser JP, Ihm P. Oral iron treatment: intestinal absorption and the influence of a meal. Dtsch Med Wochenschr. 1977; 102(29):1061-1064. doi:10.1055/s-0028-1104585
7. Auerbach M, Ballard H, Glaspy J. Clinical update: intravenous iron for anemia. Lancet. 2007;369(9572):1502-1504. doi:10.1016/S0140-6736(07) 60398-5
8. Litton E, Xiao J, Ho KM. Safety and efficacy of intravenous iron therapy in reducing the need for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ. 2013;347:f4822. doi:10.1136/bmj.f4822
9. Auerbach M, Adamson JW. How we diagnose and treat iron deficiency anemia. Am J Hematol. 2016;91(1):31-38. doi:10.1002/ajh.24201
10. Duck KA, Connor JR. Iron uptake and transport across physiological barriers. Biometals. 2016;29(4):573-591. doi:10.1007/s10534-016-9952-2
11. T.C. Sagˆlık Bakanlıgˆı Sagˆlık Hizmetleri Genel Mu¨du¨rlu¨gˆu¨, AR-GE ve Sagˆlık Teknolojisi Degˆerlendirme Dairesi. Demir Eksikligˆi ve Demir Eksikligˆi Anemisi Klinik Protokolu¨ (Versiyon 1.0). Ankara: T.C. Sagˆlık Bakanlıgˆı Yayın No:1171; 2015.
12. Erdem O¨, Erten-Bucaktepe G, Kara I·H. Aile hekimligˆi poliklinigˆine bas¸vuran kadınlarda demir eksikligˆi anemisi ve gestasyon o¨yku¨su¨ ilis¸kisi. Dicle Tıp Derg. 2009;36(2):79-85.
13. Kılınc¸ M, Yu¨regˆir GT, Eker Bic¸er H. Anemia and iron deficiency anemia in south-east Anatolia. Eur J Haematol. 2002;69(5-6):280-283. doi:10.1034/j.1600-0609.2002.02870.x
14. Avni T, Bieber A, Grossman A, et al. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clin Proc. 2015;90(1):12-23. doi:10.1016/ j.mayocp.2014.10.007
15. Karakus¸ V, Giden A, Soysal DE, et al. Eris¸kin Hastalarda anemi etiyolojisi, risk fakto¨rleri ve nu¨ksu¨n degˆerlendirilmesi. Mugˆla Sıtkı Koc¸man U¨niv Tıp Derg. 2016;3(1):1-6.
16. Seçilmiş S, İskender D, Candır BA, et al. Efficiency of intravenous iron carboxymaltose in patients with iron-deficiency anemia due to heavy menstrual bleeding: a single-center experience. Eur Rev Med Pharmacol Sci. 2022;26(10):3487-3492. doi:10.26355/eurrev_202205_28843
17. Majeed T, Solomon J, Ali RS, et al. Non-anaemic iron deficiency should be investigated with the same priority as iron deficiency anaemia in fast track colorectal clinics- retrospective cohort study. J Gastrointest Oncol. 2020;11(4):609-615. doi:10.21037/jgo- 19-451
18. Yıldız A, Albayrak M. Erişkinlerde demir eksikliği anemisi tedavisi. Turkiye Klinikleri J Hematol-Special Topics. 2017;10.3:182-187.
19. Tanrıverdi LH, Sarıcı A. Efficacy, safety, and tolerability of ferric carboxymaltose and iron sucrose in iron-deficiency anemia: a systematic review and meta-analysis of randomized controlled trials. Turk J Haematol. 2025;42(2):119-135. doi:10.4274/tjh.galenos.2025. 2025.0034
Article available in :
Volume 4, Issue 1, 2026
Page : 7-11
https://doi.org/10.51271/JCHOR-0074
Article Information
Received : 22 Kas 2025
Accepted : 02 Oca 2026
Published : 25 Şub 2026
Corresponding Author :

Ali Doğan: Department of Hematology, Faculty of Medicine, Van Yüzüncüyıl University, Van, Turkiye

[email protected]
Citation : Aydeniz G, Esen R, Doğan A. Evaluation of the response and adverse effects of intravenous iron therapy in patients with iron deficiency anemia: a single-center experience. J Curr Hematol Oncol Res. 2026;4(1):7-11.

Read: 44
Download : 40
Cited: 0
_Footer